Jin Yang Pharmaceutical Co. Ltd Capital Reinvestment Ratio
Jin Yang Pharmaceutical Co. Ltd capital reinvestment ratio. Jin Yang Pharmaceutical Co. Ltd (007370) has a Capital Reinvestment Ratio of 0.19x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩8.05 Billion) in capital expenditures (₩1.54 Billion). Check 007370 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Capital reinvestment ratio of Jin Yang Pharmaceutical Co. Ltd from 2018 to 2025. This chart tracks Jin Yang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore 007370 net assets growth trend to track the company's year-over-year net asset growth rate.
Jin Yang Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2018–2025)
Jin Yang Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Jin Yang Pharmaceutical Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.51x | ₩1.46 Billion | ₩3.67 Billion | ▲ +3285.2% |
| 2024 | 0.07x | ₩12.79 Billion | ₩947.22 Million | ▼ -58.8% |
| 2023 | 0.18x | ₩8.53 Billion | ₩1.53 Billion | ▼ -58.4% |
| 2022 | 0.43x | ₩7.45 Billion | ₩3.22 Billion | ▼ -66.2% |
| 2021 | 1.28x | ₩1.97 Billion | ₩2.52 Billion | ▲ +485.0% |
| 2020 | 0.22x | ₩6.24 Billion | ₩1.36 Billion | ▲ +113.6% |
| 2019 | 0.10x | ₩7.21 Billion | ₩736.71 Million | ▼ -67.0% |
| 2018 | 0.31x | ₩1.06 Billion | ₩327.39 Million | — |